Skip to content

Changes in Anthropometric, Biochemical and DNA Damage Parameters After 3-weeks VLCD in Severely Obese Patients

Changes in Anthropometric, Biochemical and DNA Damage Parameters After 3-weeks-567-kcal VLCD in Severely Obese Patients With BMI ≥ 35kg/m2

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05007171
Enrollment
22
Registered
2021-08-16
Start date
2019-06-14
Completion date
2020-03-09
Last updated
2021-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Weight Loss, DNA Damage

Keywords

Obesity, Very low calorie diet, Alkine comet assay, FPG oxidative comet assay, DNA damage

Brief summary

Obesity manifest with inflammation, hyperglycaemia and dyslipidaemia. These conditions disturb redox system by generating excessive reactive oxygen species (ROS) and causing oxidative stress (OS) leading to DNA damage. Very low calorie diet (VLCD) have rapid positive effect on weight loss, glucose homeostasis, inflammation and OS. The aim of study is to test the influence of 3-weeks VLCD on anthropometric, biochemical and genomic parameters in class II and III obesity patients.

Detailed description

Obesity is a chronic disease associated with chronic inflammation, insulin resistance, dyslipidemia, oxidative stress and increased risk for type 2 diabetes, cardiovascular disease, stroke and multiple cancer types. Oxidative stress can lead to base lesions of DNA which could be detected with alkine comet assay and its version with use of formamidopyrimidine DNA glycosylase-endonuclease enzyme in fresh or frozen small volume samples. Dietary caloric restriction has beneficial effects on insulin sensitivity, inflammation, oxidative stress and DNA repair. Very low calorie diet (VLCD) data are scarce, especially on the changing levels of DNA damage.This study will assess the effect of a three-week VLCD used in Special Hospital for extended treatment of Duga Resa in individuals with BMI ≥ 35kg/m2 on the level of primary and oxidative DNA damage as well as body composition and biochemical parameters.

Interventions

During 3 weeks in hospital patients will eat prepared very low calorie diet composed of 50-60% complex carbohydrates with low carbo-glycemic index, 20-25% proteins and 25-30% fat

Sponsors

Institute for Medical Research and Occupational Health
CollaboratorUNKNOWN
University of Zagreb
CollaboratorOTHER
Special Hospital for Extended Treatment of Duga Resa
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* body mass index ≥ 35 kg/m2

Exclusion criteria

* pregnancy * actual tumor diseases * recent diagnostic or treatment exposures to ionizing radiation in the period of one year * individuals not willing to stay 3 weeks under supervision under full 24 h surveillance from the medical stuff

Design outcomes

Primary

MeasureTime frameDescription
The changes in inflammation parametersBaseline, after 3 weeks of VLCDConcentration of C-reactive protein (mg/L)
The changes in HOMA indexBaseline, after 3 weeks of VLCDHOMA index is calculated according to the formula: glucose (mmol/L) x insulin (mIU/L)/22.5
The changes in lipid profileBaseline, after 3 weeks of VLCDConcentrations of triglycerides (mmo/L), LDL (mmol/L), HDL (mmol/L) cholesterol (mmol/L)
The changes in the body mass indexBaseline, after 3 weeks of VLCDBody mass index (kg/m2) is calculated by using measured body weight (kg) with measured body height (m)
The changes in the body fat massBaseline, after 3 weeks of VLCDBody fat mass (kg) assessed with bioelectrical impedance method
The changes in the skeletal muscle massBaseline, after 3 weeks of VLCDSkeletal muscle mass (kg) assessed with bioelectrical impedance method
The changes in the percent body fatBaseline, after 3 weeks of VLCDPercent body fat (%) assessed with bioelectrical impedance method
The changes in fasting glucose concentrationBaseline, after 3 weeks of VLCDConcentration of glucose (mmol/L)
The changes in urea concentrationBaseline, after 3 weeks of VLCDConcentration of urea (mmol/L)
The changes in insulin concentrationBaseline, after 3 weeks of VLCDConcentration of insulin (mIU/L)

Secondary

MeasureTime frameDescription
The changes in oxidative DNA damage assessed with FPG comet assayBaseline, after 3 weeks of VLCDValues for FPG comet assay in % for tale intensity
The changes in DNA damage assessed with alkaline comet assayBaseline, after 3 weeks of VLCDValues for alkaline comet assay in μm for tale length

Countries

Croatia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026